Skip to main content
Equibles
PTN logo

PTN · Palatin Technologies Inc

Track PTN — free

Use PTN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$12.80 -0.04 (-0.31%)
Rebalance outlook locked
Going-concern doubt — flagged May 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“While the Company has raised funding in the past, the ability to raise funding in future periods is not considered probable, as defined under the accounting standards. As such, under the requirements of ASC 205-40, management may not consider the potential for future funding in their assessment of the Company's ability to meet its obligations for the next year.”
View the 10-Q filed May 13, 2026
Market Cap
$20.53M
Shares
1.78M

PTN metrics

50 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.84
Market cap
$20.53M

Price action

19 metrics
Price change (1W)
+11.3%
Price change (30D)
+40.2%
Price change (3M)
-17.0%
Price change (6M)
-44.3%
Price change (YTD)
-25.0%
Price change (1Y)
+13.0%
Trailing year
Price change (5Y)
—
52-week high
$28.00
52-week low
$5.75
Change from 52-week high
-58.8%
Change from 52-week low
+100.7%
Annualized volatility
134.6%
Beta
-0.3
RSI (14D)
65.2
Price vs SMA 50
+22.3%
Price vs SMA 200
-28.1%
Avg volume (3M)
26,908
Relative volume
5.5
Average dollar volume
$277,618

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
1.78M

Valuation

12 metrics
P / E (TTM)
3.2
Trailing earnings · reciprocal yield 31.5%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.9
reciprocal yield 51.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-30.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-13

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$6.52M
Net income (TTM)
−$6.25M
Trailing 12 months
Diluted EPS (TTM)
$3.64
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$651.56

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+642.5%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-59.0%
Return on assets
-47.3%
Debt / equity
—
Current ratio
5.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-898.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$10.16M
Total assets
$13.23M
Total debt
$332,896

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$14.93M
Capital expenditures (TTM)
—
R&D (TTM)
$12.33M
SG&A (TTM)
$7.45M
Stock compensation (TTM)
$1.24M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
26
13F filer change QoQ
0
Institutional ownership
38.5%

Short interest

3 metrics
Short interest
19.6%
Latest settlement · 11.3 days to cover
Days to cover
11.3d
Short-squeeze score
90 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 911216 CUSIP 696077601 13F (30d) 23 filings 23 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)